4 completed, 1 terminated. 5 Phase 2, 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 4, Terminated 1 |
| Phase 1 | 4 | Completed 4 |
Follow Triferic: new trials by email Literature Review of Triferic trials Research Report on Triferic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Investigate the Pharmacokinetic Comparability of Dosing Triferic AVNU IV by Continuous Infusion and IV Bolus. Triferic - End Stage Renal Disease | Phase 1 / Phase 2 | Completed | Rockwell Medical Technologies, Inc. | 23 | 2020-06-25 | 2021-07-13 |
| A Study to Investigate the Effect of Triferic Plus Heparin Infusion Compared to Heparin Alone on Coagulation Parameters in Hemodialysis Patients Triferic, Heparin - End Stage Renal Disease | Phase 1 / Phase 2 | Completed | Rockwell Medical Technologies, Inc. | 12 | 2019-09-30 | 2020-12-02 |
| Equivalence of Triferic® (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients Triferic - End Stage Renal Disease | Phase 1 / Phase 2 | Completed | Rockwell Medical Technologies, Inc. | 27 | 2017-10-01 | 2020-11-16 |
| Triferic IRIDA (Iron-Refractory Iron-Deficiency Anemia) Protocol Fer-In-Sol, Shohl's solution, Triferic - Iron-Refractory Iron-Deficiency Anemia | Phase 2 | Terminated | Rockwell Medical Technologies, Inc. | 1 | 2017-01-17 | 2020-09-22 |
| Triferic Pediatric Pharmacokinetic Protocol Triferic - End Stage Renal Disease | Phase 1 / Phase 2 | Completed | Rockwell Medical Technologies, Inc. | 22 | 2015-11-01 | 2018-10-25 |
Kidney Failure, Chronic (4) · Iron-Refractory Iron Deficiency Anemia (1) · Renal Insufficiency, Chronic (1)
Rockwell Medical Technologies, Inc. (5)
United States (4)
Raymond D Pratt, MD, FACP (2) · Raymond D Pratt, MD FACP (1) · Raymond Pratt, MD (1) · Thomas Marbury (1)